|
Awarded Patents: Binie V. Lipps and Frederick W. Lipps
-
US patent # 5,576,297, 1996. Embodiments of Natural and Synthetic Lethal Toxin Neutralizing Factors and their Utility as Treatment for envenomation.
-
International PCT WO 95/29987, Beta Taipoxin as a Cell Growth Factor and Method. US patent # 7,129,334. Synthetic Peptide and Uses for Same for wound healing.
-
US patent # 5,565,431, 1996. Cancer Cell Inhibitor and Method.
-
Two Synthetic Peptides for Treatment and Prevention of Cancers US patent # 7,183,258 B2.
-
US patent # 5,648,339, 1997. Herpoxin: Herpes Virus Inhibitor and Method.
-
Synthetic Peptide Inhibitor to DNA Viruses. US patent # 7,399,825 B2 2008.
-
US patent # 5,744,449 1998. Lethal Toxin Neutralizing Factors.
-
International PCT WO 02/03922 A2. Synthetic Peptide for Neurological Disorders.*
-
2003 PCT WO 03/A2, 2003. Diagnosis and treatment for immunoglobin E (IgE) Implicated Disorders.
-
Inhibitor for RNA viruses US patent # 6,924,353 B2 2005.
* Patent # 8. International PCT WO 02/03922 A2. Synthetic Peptide for the Treatment of Neurological Disorders is licensed out to Nymox Pharmaceuticals.
|
